HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products.
about
An immunogenic peptide in the A-box of HMGB1 protein reverses apoptosis-induced tolerance through RAGE receptorHigh mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptorRAGE: a new frontier in chronic airways diseaseDAMPs, MAMPs, and NAMPs in plant innate immunityHMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrinSepsis: in search of cure.The IKKα-dependent NF-κB p52/RelB noncanonical pathway is essential to sustain a CXCL12 autocrine loop in cells migrating in response to HMGB1.Controlling the receptor for advanced glycation end-products to conquer diabetic vascular complicationsThe HMGB1-RAGE axis mediates traumatic brain injury-induced pulmonary dysfunction in lung transplantation.Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected]RAGE expression in human T cells: a link between environmental factors and adaptive immune responses.Pathways involved in the synergistic activation of macrophages by lipoteichoic acid and hemoglobin.HMGB1 in health and disease.HMGB1 promotes a p38MAPK associated non-infectious inflammatory response pathway in human fetal membranes.The C-terminal acidic tail is responsible for the inhibitory effects of HMGB1 on efferocytosis.Advanced glycation end products induce peroxisome proliferator-activated receptor γ down-regulation-related inflammatory signals in human chondrocytes via Toll-like receptor-4 and receptor for advanced glycation end products.Mechanical ventilation enhances HMGB1 expression in an LPS-induced lung injury model.Soluble HMGB1 is a novel adipokine stimulating IL-6 secretion through RAGE receptor in SW872 preadipocyte cell line: contribution to chronic inflammation in fat tissueAnti-HMGB1 monoclonal antibody ameliorates immunosuppression after peripheral tissue trauma: attenuated T-lymphocyte response and increased splenic CD11b (+) Gr-1 (+) myeloid-derived suppressor cells require HMGB1.Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100BModulation of macrophage efferocytosis in inflammation.Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.Poly(ADP-ribosyl)ation of high mobility group box 1 (HMGB1) protein enhances inhibition of efferocytosisModulation of Macrophage Polarization and HMGB1-TLR2/TLR4 Cascade Plays a Crucial Role for Cardiac Remodeling in Senescence-Accelerated Prone Mice.Toll-like receptor 4 signaling: A common pathway for interactions between prooxidants and extracellular disulfide high mobility group box 1 (HMGB1) protein-coupled activation.Damage-associated molecular patterns (DAMPs) in preterm labor with intact membranes and preterm PROM: a study of the alarmin HMGB1High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger MoleculeManaging chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift.Characterization of the Inflammatory Properties of Actively Released HMGB1 in Juvenile Idiopathic Arthritis.Glycyrrhizin protects against porcine endotoxemia through modulation of systemic inflammatory responseCannabinoid receptor 2 protects against acute experimental sepsis in miceAGE restriction in diabetes mellitus: a paradigm shift.Anti-septic effects of dabrafenib on HMGB1-mediated inflammatory responses.HMGB1 acts in synergy with lipopolysaccharide in activating rheumatoid synovial fibroblasts via p38 MAPK and NF-κB signaling pathways.HMGB1 level in cerebrospinal fluid as a complimentary biomarker for the diagnosis of tuberculous meningitisThrombin inhibits HMGB1-mediated proinflammatory signaling responses when endothelial protein C receptor is occupied by its natural ligand.Clinical chorioamnionitis is characterized by changes in the expression of the alarmin HMGB1 and one of its receptors, sRAGEHMGB1-LPS complex promotes transformation of osteoarthritis synovial fibroblasts to a rheumatoid arthritis synovial fibroblast-like phenotypeHeat shock proteins and high mobility group box 1 protein lack cytokine function.
P2860
Q24324028-D9A4C70D-06DC-464A-90C5-22597BF1C790Q24604370-F6B6FEB8-C2CD-4CC9-8D48-4BEA873B94BCQ27025295-505ACB68-A52C-4B1F-98E2-D6CF0720FB92Q28066924-194F46C9-10EF-41FE-8387-CDD8C4555A4CQ28506871-13EDF208-65A8-414F-BD22-43FEA487C5C1Q30251753-D0FE9E36-7EEF-4E7D-8765-6014CE5BB257Q30505780-241F415D-7C0D-4E2C-BE55-DA39E8E2EBB3Q33609776-F921C793-483F-4FA9-BC96-ED34E0004FF7Q33745462-C2821862-CADD-47C7-99A5-0D2251938DBAQ34043446-1473A642-03CA-4F63-A00F-FD3EDA7B1B98Q34235391-CAEFF830-5CC7-473B-AB6A-4CC90ACB3F55Q34448199-A4B59431-7B85-4082-B8CF-67D6E55A0C55Q34622835-493AB8C4-2764-48D0-AC76-1BD8CEA46BD7Q34626420-9930C610-D52C-4D11-A30E-E0421E403309Q34769562-BDBE0D60-7742-4EAB-B5D0-223F8BEFD090Q34776819-B38AF4BF-4757-4CAE-B400-6D8083E9EFC8Q34994835-86FDE5B2-5BB1-4903-BEA2-216AE337DC52Q35000952-54CCC4D5-EF0E-41E1-8C6A-F3E5B909E13AQ35076030-175E141A-34D4-47A0-9F41-2B38AD9B4C11Q35579991-9C198978-D6F2-4A9E-A774-EB657F9FFFC4Q35927561-0A5EDCFF-E8B7-4C2F-A3F7-63EAF0EE294FQ35948515-28239F7E-E4DB-4513-92B1-925E0E2D57EDQ35973298-FF26D28F-5BCD-4F17-BDDB-7BA3835F120BQ35987094-973721D3-AB26-4018-93DB-7B97907D9BBEQ36145679-D0B7DF8D-95AF-41E8-AEF7-D1F76C29D9A8Q36165681-AAC60F68-8194-4B53-B74B-E47DB4F75B1EQ36231977-1495A785-184A-4758-9DD1-0AD240389212Q36322388-CDD92DD1-BC0A-495D-9778-0D5334174D35Q36796216-D9E1604F-9103-44DB-B2CA-4B9D4445DFB6Q36827894-B798842E-B90B-4D3E-B818-03C9CF5771EAQ36902374-2ED9B351-456F-4A6E-ADFD-395E7F920A7DQ36921431-7337A406-EF3C-418F-91CB-3B14E419B20AQ37003623-A682515C-11C1-4513-BFAD-1D8B34E64DB2Q37024803-30A2406B-49D2-46A8-8804-8E3F72EF963AQ37326998-0A1162DD-65EF-43A5-9326-E92511734EBAQ37334747-30ED3106-CB4C-4821-8988-65463DBE5FC8Q37347450-AAB0D3FF-CBB7-4086-A05A-C98B1DAC6076Q37556492-316572FB-8F76-4BB1-93D3-AC18E6CC67D6Q37620697-D36EBF94-ED38-4BEF-89F4-1CEBB6619A36Q37825717-12105B76-D501-4F1F-A2B6-53900AFDA96C
P2860
HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
HMGB1 enhances the proinflamma ...... vanced glycation end products.
@en
HMGB1 enhances the proinflamma ...... vanced glycation end products.
@nl
type
label
HMGB1 enhances the proinflamma ...... vanced glycation end products.
@en
HMGB1 enhances the proinflamma ...... vanced glycation end products.
@nl
prefLabel
HMGB1 enhances the proinflamma ...... vanced glycation end products.
@en
HMGB1 enhances the proinflamma ...... vanced glycation end products.
@nl
P2093
P356
P1476
HMGB1 enhances the proinflamma ...... vanced glycation end products.
@en
P2093
Gu-Sheng Tang
Sheng-Ming Dai
Yang-Hua Qin
Zhi-Wei Wang
P304
P356
10.4049/JIMMUNOL.0900390
P407
P577
2009-11-01T00:00:00Z